0001288123-18-000015.txt : 20180622
0001288123-18-000015.hdr.sgml : 20180622
20180622122842
ACCESSION NUMBER: 0001288123-18-000015
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180620
FILED AS OF DATE: 20180622
DATE AS OF CHANGE: 20180622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wright Timothy
CENTRAL INDEX KEY: 0001383313
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29089
FILM NUMBER: 18913903
MAIL ADDRESS:
STREET 1: C/O ANTIGENICS INC
STREET 2: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGENUS INC
CENTRAL INDEX KEY: 0001098972
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 061562417
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-674-4410
MAIL ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIGENICS INC /DE/
DATE OF NAME CHANGE: 19991115
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2018-06-20
0
0001098972
AGENUS INC
AGEN
0001383313
Wright Timothy
C/O ANTIGENICS INC
3 FORBES ROAD
LEXINGTON
MA
02421
1
0
0
0
Stock Option, right to buy
5.65
2018-06-20
4
A
0
37500
5.65
A
2019-03-02
2028-03-02
Common Stock
37500
37500
D
Restricted Stock Unit
2018-06-20
4
A
0
15957
A
2019-04-19
2019-04-19
Common Stock
15957
15957
D
Option was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, vesting on March 2, 2019.
RSU was granted on April 19, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meting on June 20, 2018. Award vests on April 19, 2019.
Christine M. Klaskin, by Power of Attorney
2018-06-22